14 stories tagged with #biopharma, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Biopharma"
China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer.…
Hansa Biopharma AB (publ) (HNSBF) Discusses Top Line Results from PAES Study on Imlifidase in Highly Sensitized Kidney Transplant Patients - Slideshow
2026-05-27. The following slide deck was published by Hansa Biopharma AB (publ) in conjunction with this event.…
Hansa Biopharma AB (publ) (HNSBF) Discusses Top Line Results from PAES Study on Imlifidase in Highly Sensitized Kidney Transplant Patients Transcript
Hansa Biopharma AB (publ) (HNSBF) Discusses Top Line Results from PAES Study on Imlifidase in Highly Sensitized Kidney Transplant Patients May 27, 2026 8:00...…
South Korea: Asia's Second Innovation Engine
South Korea has been the second most important contributor to the growth of Asian innovation in recent years, outperforming Japan in several areas. Read more here.…
Hansa Biopharma trial results to be presented at ATC in June
Benitec Biopharma’s SWOT analysis: gene therapy stock shows clinical promise
Form 13G Sunshine Biopharma Inc. For: 22 May
Apogee Therapeutics: Targeting Atopic Dermatitis
Apogee Therapeutics, Inc. is rated a Hold, driven by promising data for the lead asset zumilokibart in atopic dermatitis. Read more on APGE stock here.…
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Hansa Biopharma AB (publ) (HNSBF) Discusses Out-Licensing Agreement With SERB for Idefirix Commercialization in Europe and MENA Transcript
Hansa Biopharma AB (publ) (HNSBF) Discusses Out-Licensing Agreement With SERB for Idefirix Commercialization in Europe and MENA May 19, 2026 9:00 AM...…
Hansa Biopharma AB (publ) (HNSBF) Discusses Out-Licensing Agreement With SERB for Idefirix Commercialization in Europe and MENA - Slideshow
2026-05-19. The following slide deck was published by Hansa Biopharma AB (publ) in conjunction with this event.…
Cohere acquires Reliant AI, expanding presence in life sciences
Deal is second such transaction for Toronto-based Cohere this year after announcing merger with German AI company Aleph Alpha…
ArriVent BioPharma: Stronger Balance Sheet And Pipeline Upside Reinforce Our Bull Case
ArriVent ended Q1 with $326.4 million of cash and extended its expected runway from Q3 2027 to Q4 2027, reducing near-term risk. Read why AVBP stock is a strong buy.…